Urinary zinc excretion and acute phase response in cancer patients
β Scribed by Melichar, B. ;Jandik, P. ;Tichy, M. ;Malir, F. ;Mergancova, J. ;Voboril, Z.
- Publisher
- Springer-Verlag
- Year
- 1994
- Tongue
- English
- Weight
- 302 KB
- Volume
- 72
- Category
- Article
- ISSN
- 1432-1440
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Urinary zinc excretion is known to be increased in cancer patients, but the pathogenesis of this phenomenon remains uncertain. Both skeletal muscle catabolism and renal tubular cell dysfunction have been proposed to explain this observation. We have investigated urinary zinc and N-acetyl-~-D-glucosa
Twenty-one β€-thalassemia major patients were included to study urinary zinc and copper excretion before and after high dose desferrioxamine (DF). The mean basal zinc excretion (1193.72 Β± 1079.64 g/24 hr) was higher than the mean zinc excretion observed in controls (427.6 Β± 74.37 g/24 hr) (P < 0.001)